Each tablet contains
Meloxicam. 2.5 mg
Excipients. Q.S.
Each tablet contains
Meloxicam. 2.5 mg
Excipients. Q.S.
Management of inflammation and pain associated with chronic osteoarthritis.
Relief of acute pain and inflammation post-orthopedic or soft-tissue surgery.
Control of chronic musculoskeletal pain in companion animals.
Reduction of pain and discomfort due to trauma.
Alleviation of fever associated with various inflammatory conditions.
Meloxicam is a Non-Steroidal Anti-Inflammatory Drug (NSAID) that primarily acts by preferentially inhibiting the enzyme Cyclooxygenase-2 (COX-2). COX 2 is primarily responsible for producing pro-inflammatory prostaglandins from arachidonic acid. By blocking COX-2 , Meloxicam effectively reduces the synthesis of these inflammatory mediators, providing potent analgesic (pain-relieving), anti-inflammatory, and antipyretic (fever-reducing) effects. Its preferential selectivity helps reduce common NSAID side effects, particularly gastrointestinal irritation, compared to non-selective inhibitors.
COX-2 preferential inhibition offers a reduced risk of side effects.
Provides effective, sustained pain relief to support mobility.
Scored tablets facilitate accurate and flexible dosing across patient weights.
Reduces joint stiffness and tenderness, improving quality of life.
Suitable for long-term supportive therapy in chronic pain cases.
Dosage must be administered strictly under veterinary guidance.
Initial Dose (Day 1): 0.2 mg/Kg body weight, once daily.
Maintenance Dose (Subsequent Days): 0.1 mg/Kg body weight, once daily till desired resulted are observed.
Method: Administer orally, either with food or directly into the mouth.
Duration: Treatment length is determined by the veterinary physician based on the patient's response and condition severity.
Strip of 10 chewable tablets
Tablet
Asia
America
Middle East
Africa
Anz
south America
EU
India